Unknown x corrected? [RSABE / ABEL]

posted by Qilex Homepage – France, 2016-09-21 14:25 (3156 d 12:47 ago) – Posting: # 16656
Views: 26,086

Hi Detlew

❝ But I'm not quite sure if this applies in our context.

❝ What makes me curious about this is that in the various papers about scaled ABE and also about Individual BE (where (µTR)2 is also part of the IBE criterion) there is not any hint of such a 'correction'.

:ponder:.


Any update on the "corrected" x value? The two Lászlós presented a method to "calculate the confidence limits of the reference-scaled SABE by modifying the method of Hyslop et al". The latter method "utilizes Howe's approximation I". The FDA draft guidance on progesterone states that "the method of obtaining the upper confidence bound is based on Howe’s Approximation I".

  1. Hyslop T, Hsuan F, Holder DJ. A small sample confidence interval approach to assess individual bioequivalence. Stat Med 2000;19(20):2885–2897.
  2. Tothfalusi L, Endrenyi L, Arieta AG. Evaluation of bioequivalence for highly variable drugs with scaled average bioequivalence. Clin Pharmacokinet 2009;48(11):725–743.
  3. Tothfalusi L, Endrenyi L, Midha KK, et al. Evaluation of the bioequivalence of highly-variable drugs and drug products. Pharm Res 2001;18(6):728–733.

Philippe

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
119 visitors (0 registered, 119 guests [including 6 identified bots]).
Forum time: 03:13 CEST (Europe/Vienna)

Only dead fish go with the current.    Scuba divers' proverb

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5